The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize
mRNA is like Hermes, delivering the genetic code to cellular construction sites, so it has long been of interest, but only to a small group of scientists, and only demonstrating its remarkable efficacy in coronavirus disease 2019 (COVID-19) vaccines allowed it to go out into the open. Therefore, now...
| Autores principales: | , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022-09-01
|
| Colección: | Molecular Therapy: Nucleic Acids |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S216225312200172X |